Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers. Its targeted radiotherapies utilize purpose-built vectors to specifically target high-energy radio-isotopes to tumors and metastatic cancer lesions. This new class of drugs holds tremendous untapped therapeuticand commercial potential, and has generated over $10B in recent M&A, financings, and product launches – and are expected to comprise 70% of the $30B nuclear medicine market by 2030.It was launched by adMare BioInnovations, Canada’s global life sciences venture, in partnership with industry leaders AbCellera, and some of the country’s most successful scientist entrepreneurs.

Health Diagnostics

Health Care

Biotechnology

Abdera Therapeutics

Lori Lyons-Williams

Stella Chin

Philippe Bishop M.D.

Emma Cummins

Mike Abrams

Lana Janes

Alison Armour

Kelly Parker

Kawa Chiu

The Operations and Support Team at Abdera Therapeutics ensures seamless daily operations by managing IT infrastructure, providing executive administrative support, coordinating human resources activities, overseeing laboratory operations, and managing general organizational logistics. Their work enables the scientific and executive teams to focus on advancing targeted alpha therapies for cancer patients.

Operations and Support Team

Leadership Team

Directors Team

��

Operations and Support Team

About

Team members

Other teams at Abdera Therapeutics

Leadership Team

Directors Team

��������

Operations and Support Team

About

Team members

Other teams at Abdera Therapeutics

Leadership Team

Directors Team

��